AAAAAA

   
Results: 1-19 |
Results: 19
Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study
Authors: Bodner-Adler, B Bodner, K Obermair, A Czerwenka, K Petru, E Leodolter, S Mayerhofer, K
Citation: B. Bodner-adler et al., Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study, ANTICANC R, 21(4B), 2001, pp. 3069-3074
Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients
Authors: Mayerhofer, K Bodner, K Saletu, B Bodner-Adler, B Anderer, P Hefler, L Schindl, M Kaider, A Leodolter, S Kainz, C
Citation: K. Mayerhofer et al., Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: A prospective EEG mapping study in 28 patients, ANTICANC R, 21(1B), 2001, pp. 803-808
Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN)
Authors: Bodner-Adler, B Hefler, L Bodner, K Leodolter, S Frischmuth, K Kainz, C Mayerhofer, K
Citation: B. Bodner-adler et al., Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN), ANTICANC R, 21(1B), 2001, pp. 809-812
Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients
Authors: Bodner, K Bodner-Adler, B Obermair, A Windbichler, G Petru, E Mayerhofer, S Czerwenka, K Leodolter, S Kainz, C Mayerhofer, K
Citation: K. Bodner et al., Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients, GYNECOL ONC, 81(2), 2001, pp. 160-165
Perineal lacerations during spontaneous vaginal delivery
Authors: Bodner, K Bodner-Adler, B Wagenbichler, P Kaider, A Leodolter, S Husslein, P Mayerhofer, K
Citation: K. Bodner et al., Perineal lacerations during spontaneous vaginal delivery, WIEN KLIN W, 113(19), 2001, pp. 743-746
Risk factors for third-degree perineal tears in vaginal delivery, with an analysis of episiotomy types
Authors: Bodner-Adler, B Bodner, K Kaider, A Wagenbichler, P Leodolter, S Husslein, P Mayerhofer, K
Citation: B. Bodner-adler et al., Risk factors for third-degree perineal tears in vaginal delivery, with an analysis of episiotomy types, J REPRO MED, 46(8), 2001, pp. 752-756
Influence of different maternal birth positions on perineal trauma and neonatal parameters during spontaneous vaginal delivery
Authors: Bodner-Adler, B Bodner, K Joura, EA Husslein, P Wagenbichler, P Kaider, A Mayerhofer, K
Citation: B. Bodner-adler et al., Influence of different maternal birth positions on perineal trauma and neonatal parameters during spontaneous vaginal delivery, GEBURTSH FR, 61(10), 2001, pp. 766-770
Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy
Authors: Mayerhofer, K Bodner, K Bodner-Adler, B Schindl, M Kaider, A Hefler, L Zeillinger, R Leodolter, S Joura, EA Kainz, C
Citation: K. Mayerhofer et al., Interleukin-8 serum level shift in patients with ovarian carcinoma undergoing paclitaxel-containing chemotherapy, CANCER, 91(2), 2001, pp. 388-393
Tumor anemia and thrombocytosis in patients with vulvar cancer
Authors: Hefler, L Mayerhofer, K Leibman, B Obermair, A Reinthaller, A Kainz, C Tempfer, C
Citation: L. Hefler et al., Tumor anemia and thrombocytosis in patients with vulvar cancer, TUMOR BIOL, 21(5), 2000, pp. 309-314
Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: Efficacy and adverse effects with special consideration of peripheral neurotoxicity
Authors: Mayerhofer, K Bodner-Alder, B Bodner, K Leodolter, S Kainz, C
Citation: K. Mayerhofer et al., Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: Efficacy and adverse effects with special consideration of peripheral neurotoxicity, ANTICANC R, 20(5C), 2000, pp. 4047-4050
A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: A prospective study in patients with ovarian cancer
Authors: Mayerhofer, K Bodner-Adler, B Bodner, K Saletu, B Schindl, M Kaider, A Hefler, L Leodolter, S Kainz, C
Citation: K. Mayerhofer et al., A paclitaxel-containing chemotherapy does not cause central nervous adverse effects: A prospective study in patients with ovarian cancer, ANTICANC R, 20(5C), 2000, pp. 4051-4055
Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers
Authors: Mayerhofer, K Bodner, K Aktas, C Schindl, M Kaider, A Leodolter, S Joura, EA Kainz, C
Citation: K. Mayerhofer et al., Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers, ANTICANC R, 20(2B), 2000, pp. 1281-1284
Serum homocyst(e)ine levels in women with preeclampsia
Authors: Mayerhofer, K Hefler, L Zeisler, H Tempfer, C Bodner, K Stockler-Ipsiroglu, S Muhl, A Kaider, A Schatten, C Leodolter, S Husslein, P Kainz, C
Citation: K. Mayerhofer et al., Serum homocyst(e)ine levels in women with preeclampsia, WIEN KLIN W, 112(6), 2000, pp. 271-275
Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients
Authors: Mayerhofer, K Bodner, K Saletu, B Bodner-Adler, B Anderer, P Hefler, L Kaider, A Leodolter, S Kainz, C
Citation: K. Mayerhofer et al., Paclitaxel does not cause central nervous adverse effects: A prospective vigilance-controlled EEG mapping study in ovarian cancer patients, WIEN KLIN W, 112(23), 2000, pp. 1007-1013
Serum soluble Fas levels in ovarian cancer
Authors: Hefler, L Mayerhofer, K Nardi, A Reinthaller, A Kainz, C Tempfer, C
Citation: L. Hefler et al., Serum soluble Fas levels in ovarian cancer, OBSTET GYN, 96(1), 2000, pp. 65-69
p53 antibody response in patients with vulvar cancer
Authors: Mayerhofer, K Hefler, L Schindl, M Concin, N Frischmuth, K Leodolter, S Zeillinger, R Reinthaller, A Kainz, C
Citation: K. Mayerhofer et al., p53 antibody response in patients with vulvar cancer, ANTICANC R, 19(3B), 1999, pp. 2323-2326
Humoral p53 antibody response is a prognostic parameter in ovarian cancer
Authors: Mayerhofer, K Tempfer, C Kucera, E Hefler, L Zeisler, H Kainz, C Zeillinger, R Sliutz, G
Citation: K. Mayerhofer et al., Humoral p53 antibody response is a prognostic parameter in ovarian cancer, ANTICANC R, 19(1B), 1999, pp. 875-878
Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases
Authors: Mayerhofer, K Obermair, A Windbichler, G Petru, E Kaider, A Hefler, L Czerwenka, K Leodolter, S Kainz, C
Citation: K. Mayerhofer et al., Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases, GYNECOL ONC, 74(2), 1999, pp. 196-201
Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
Authors: Hefler, L Tempfer, C Heinze, G Mayerhofer, K Breitenecker, G Leodolter, S Reinthaller, A Kainz, C
Citation: L. Hefler et al., Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients, BR J CANC, 81(5), 1999, pp. 855-859
Risultati: 1-19 |